Thermogenesis announces $3 million private placement priced at-the-market under nasdaq rules

Rancho cordova, calif. , march 16, 2023 /prnewswire/ -- thermogenesis holdings, inc. (nasdaq: thmo), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has entered into definitive agreements for the purchase and sale of 1,071,429 shares of its common stock (or common stock equivalents) and warrants to purchase 1,071,429 shares of its common stock at a purchase price of $2.80 per share of common stock (or common stock equivalent) and associated warrant in a private placement priced at-the-market under nasdaq rules.
THMO Ratings Summary
THMO Quant Ranking